Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is -15.82%
Standalone Net Profit
YoY Growth in quarter ended Jun 2026 is 40.19%
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is 35.42%
Interest
YoY Growth in quarter ended Jun 2026 is -42.65%
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Compare Quarterly Results Of Beta Drugs Ltd With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2026 is 2.72% vs 8.09% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -15.82%
Quarterly - Standalone Net Profit
QoQ Growth in quarter ended Jun 2026 is 11.26% vs 64.00% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 40.19%
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2026 is 4.20% vs 49.01% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 35.42%
Quarterly - Interest
QoQ Growth in quarter ended Jun 2026 is -44.25% vs -9.46% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -42.65%
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025






